Search Job Title Only
News By Subject
News by Disease
News By Date
Get Our FREE
): Interim Results for the Six Months Ended 31 March 2010
5/24/2010 11:06:42 AM
Business Financial Newswire - Pharmaceutical developer Phytopharm narrowed its first-half loss after tax to £1.91m from £2.21m.
(PYM.L): Interim Management Statement Q1 2010
ACADIA Pharmaceuticals, Inc.
(ACAD) to Announce First Quarter 2010 Financial Results on May 10, 2010
(PYM.L) Shares Soar on Parkinson's Drug Promise; Stock Up 339.64% at Market Close
(DNDN) Cash In on Drug Approval
(PYM.L) Announces Appointment of Research and Development Director
(ALKS) Takes Bigger 4Q Loss As Revenue Slips
(PYM.L): Interim Management Statement
Watson Pharmaceuticals, Inc.
(WPI) Profit Tops
(PYM.L) Enters An Agreement With
To Evaluate The Potential Efficacy Of Cogane(TM) In The Treatment Of Huntington's Disease (HD)
(NVAX) 1Q Loss Widens; Revenue Jumps
comments powered by Disqus.
comments powered by
Biotech/Pharma - Earnings
Biotech/Pharma - Earnings (World)